Bisphenol-A: A new diabetogenic factor?

Hormones

Volumn 9, Issue 2, 2010, Pages 118-126

  Alonso Magdalena, Paloma ^a,b   Ropero, Ana Behn ^a,b   Soriano, Sergi ^a,b   Quesada, Ivan ^a,b   Nadal, Angel ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Bisphenol a; Diabetes; Estradiol; Estrogen receptors; Glucose homeostasis; Islet of langerhans

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; DIOXIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; ORGANOCHLORINE PESTICIDE; PHTHALIC ACID DERIVATIVE; POLYCHLORINATED BIPHENYL;

DIABETES MELLITUS; DIABETOGENESIS; ENERGY BALANCE; ENVIRONMENTAL EXPOSURE; ESTROGEN ACTIVITY; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; REVIEW; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY;

EID: 77953181779     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401277     Document Type: Review

References (85)

1. Wild S, Roqlic C, Green A, Sicree R, King H, 2004 Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053.
2. Herman MA, Kahn BB, 2006 Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J Clin Invest 116: 1767-1775.
3. Rosen ED, Spiegelman BM, 2006 A dipocytes as regulators of energy balance and glucose homeostasis. Nature 444: 847-853.
4. Ropero AB, Alonso-Magdalena P, Quesada I, Nadal A, et al, 2008 The role of estrogen receptors in the control of energy and glucose homeostasis. Steroids 73: 874-879.
5. Fritsche L, Weigert C Haring HU, Lehmann R, 2008 How insulin receptor substrate proteins regulate the metabolic capacity of the liver--implications for health and disease. Curr Med Chem 15: 1316-1329.
6. Kahn CR, 2003 Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes. Exp Diabesity Res 4: 169-182.
7. Kahn SE, Hull RL, Utzschneider KM, et al, 2006 Mechanisms linking obesity to insulin resistance andtype 2 diabetes. Nature 444: 840-846.
8. Kahn SE, Zraika S, Utzschneider KM, et al, 2009 The beta cell lesion in type 2 diabetes: there has to be aprimary functional abnormality. Diabetologia 52: 1003-1012.
9. Biddinger SB, Kahn CR, 2006 From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol 68: 123-158.
10. Heldring N, Pike A, Anderson S, et al, 2007 Estrogenreceptors: how do they signal and what are their targets. Physiol Rev 87: 905-931.
11. Barros RP, Machado UF, Gustafsson JA, et al, 2006 Estrogen receptors: new players in diabetes mellitus. Trends Mol Med 12: 425-431.
12. Nadal A, Alonso-Magdalena P, Soriano S, et al, 2009 The pancreatic beta-cell as a target of estrogens and xenoestrogens: Implications for blood glucose homeostasis and diabetes. Mol Cell Endocrinol 304: 63-68.
13. Livingstone C, Collison M, 2002 Sex steroids and insulin resistance. Clin Sci (Lond) 102: 151-166.
14. Godsland IF, 2005 Oestrogens and insulin secretion. Diabetologia 48: 2213-2220.
15. Godsland IF, 1996 The influence of female sex steroidson glucose metabolism and insulin action. J Intern Med Suppl 738: 1-60.
16. Wynn V, Doar JW, 1966 Some effects of oral contraceptives on carbohydrate metabolism. Lancet 2: 715-719.
17. Tchernof A, Calles-Escandon J, Sites CK, et al, 1998 Menopause, central body fatness, and insulin resistance: effects of hormone-replacement therapy. Coron Artery Dis 9: 503-511.
18. Bryzgalova G, Lundholm L, Portwood N, et al, 2008 Mechanisms of antidiabetogenic and body weightloweringeffects of estrogen in high-fat diet-fed mice. Am J Physiol Endocrinol Metab 295: E904-912.
19. Salpeter SR, Walsh JM, Ormiston TM, Greyber E, Buckley NS, Salpeter EE, 2006 Meta-analysis: effectof hormone-replacement therapy on components ofthe metabolic syndrome in postmenopausal women. Diabetes Obes Metab 8: 538-554.
20. Jones ME, Thorburn AW, Britt KL, et al, 2000 A romatase deficient(ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 97: 12735-12740.
21. Heine PA, Taylor JA, Iwamoto GA, et al, 2000 Increasedadipose tissue in male and female estrogen receptoralphaknockout mice. Proc Natl Acad Sci USA 97:12729-12734.
22. Zirilli L, Rochira V, Diazzi C, Caffagni G, Carani C, 2008 Human models of aromatase deficiency. J Steroid Biochem Mol Biol 109: 212-218.
23. Smith EP, Boyd J, Frank GR, et al, 1994 Estrogen resistance caused by a mutation in the estrogen-receptorgene in a man. N Engl J Med 331: 1056-1061.
24. Gallagher CJ, Langefeld CD, Gordon CJ, et al, 2007 Association of the estrogen receptor-alpha gene withthe metabolic syndrome and its component traits inAfrican-American families: the Insulin ResistanceAtherosclerosis Family Study. Diabetes 56: 2135-2141.
25. Musatov S, Chen W, Pfaff DW, et al, 2007 Silencing ofestrogen receptor alpha in the ventromedial nucleus ofhypothalamus leads to metabolic syndrome. Proc NatlAcad Sci USA 104: 2501-2506.
26. Liang YQ, Akishita M, Kim S, et al, 2002 Estrogen receptorbeta is involved in the anorectic action of estrogen. Int J Obes Relat Metab Disord 26: 1103-1109.
27. Bryzgalova G, Gao H, Ahren B, et al, 2006 Evidencethat oestrogen receptor-alpha plays an important role inthe regulation of glucose homeostasis in mice: insulinsensitivity in the liver. Diabetologia 49: 588-597.
28. Barros RP, Machado UF, Warner M, Gustafsson JA, 2006 Muscle GLUT4 regulation by estrogen receptorsERbeta and E Ralpha. Proc Natl Acad Sci USA 103:1605-1608.
29. Cooke PS, Heine PA, Taylor JA, Lubahn DB, 2001 Therole of estrogen and estrogen receptor-alpha in maleadipose tissue. Mol Cell Endocrinol 178: 147-154.
30. Couse JF, Korach KS, 1999 Estrogen receptor nullmice: what have we learned and where will they leadus? Endocr Rev 20: 358-417.
31. Naaz A, Zakroczymski M, Heine P, 2002 Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor alpha (ERalpha): a potential role for estrogen receptor beta (ERbeta). Horm Metab Res 34: 758-763.
32. Penza M, Montani C, Romani A, et al, 2006 Genisteinaffects adipose tissue deposition in a dose-dependentand gender-specific manner. Endocrinology 147: 5740-5751.
33. Shin JH, Hur JY, Seo HS, et al, 2007 The ratio of estrogenreceptor alpha to estrogen receptor beta in adiposetissue is associated with leptin production and obesity. Steroids 72: 592-599.
34. Alonso-Magdalena P, Ropero AB, Carrera MP, et al, 2008 Pancreatic insulin content regulation by the estrogenreceptor E Ralpha. PLoS One: 3 e2069.
35. Le May C, Chu K, Hu M, et al, 2006 Estrogens protectpancreatic beta-cells from apoptosis and prevent insulin deficient diabetes mellitus in mice. Proc Natl Acad Sci USA 103: 9232-9237.
36. Soriano S, Ropero AB, Alonso-Magdalena P, et al, 2009 Rapid regulation of K (ATP) channel activity by17{beta}-estradiol in pancreatic {beta}-cells involvesthe estrogen receptor {beta} and the atrial natriureticpeptide receptor. Mol Endocrinol 23: 1973-1982.
37. Kavlock RJ, Daston GP, DeRosa C, et al, 1996 Researchneeds for the risk assessment of health and environmentaleffects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ Health Perspect 104: Suppl 4: 715-740.
38. Colborn T, 1995 Environmental estrogens: health implicationsfor humans and wildlife. Environ HealthPerspect 103: Suppl 7: 135-136.
39. Dodds EC, Lawson W, 1936 Synthetic estrogenic agentswithout the phenanthrene nucleus. Nature 137: 996.
40. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM, 2009 Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 30: 75-95.
41. Olea N, Pulgar R, Prez P, et al, 1996 Estrogenicity ofresin-based composites and sealants used in dentistry. Environ Health Perspect 10: 298-305.
42. Kang JH, Kondo F, Katayama Y, 2006 Human exposureto bisphenol A. Toxicology 226: 79-89.
43. Vandenberg LN, Hauser R, Marcus M, Olea N, WelshonsWV, 2007 Human exposure to bisphenol A (BPA). Reprod Toxicol 24: 139-177.
44. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL, 2005 Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 113: 391-395.
45. Sajiki J, Takahashi K, Yonekubo J, 1999 Sensitive methodfor the determination of bisphenol-A in serum using twosystems of high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 736: 255-261.
46. Takeuchi T, Tsutsumi O, 2002 Serum bisphenol a concentrationsshowed gender differences, possibly linkedto androgen levels. Biochem Biophys Res Commun 291: 76-78.
47. Richter CA, Birnbaum LS, Farabollini F, et al, 2007 Invivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 24: 199-224.
48. Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A, 2006 The estrogenic effect of bisphenol Adisrupts pancreatic beta-cell function in vivo andinduces insulin resistance. Environ Health Perspect 114: 106-112.
49. Bindhumol V, Chitra KC, Mathur PP, 2003 Bisphenol A induces reactive oxygen species generation in the liverof male rats. Toxicology 188: 117-124.
50. Kabuto H, Hasuike S, Minagawa N, Shishibori T, 2003 Effects of bisphenol A on the metabolisms of activeoxygen species in mouse tissues. Environ Res 93: 31-35
51. Nunez AA, Kannan K, Giesy JP, Fang J, Clemens LG, 2001 Effects of bisphenol A on energy balance and accumulationin brown adipose tissue in rats. Chemosphere 42: 917-922.
52. Seidlova-Wuttke D, Jarry H, Christoffel J, Rimoldi G, Wuttke W, 2005 Effects of bisphenol-A (BPA), dibutylphtalate(DBP), benzophenone-2 (BP2), procymidone(Proc), and linurone (Lin) on fat tissue, a variety ofhormones and metabolic parameters: a 3 months comparisonwith effects of estradiol (E2) in ovariectomized(ovx) rats. Toxicology 213: 13-24.
53. Sakurai K, Kawazuma M, Adachi T, et al, 2004 Bisphenol A affects glucose transport in mouse 3T3-F442 A adipocytes. Br J Pharmacol 141: 209-214.
54. Masuno H, Iwanami J, Kidani T, Sakayama K, Honda K, 2005 Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol Sci 84: 319-327.
55. Masuno H, Kidani T, Sekiya K, et al, 2002 Bisphenol A in combination with insulin can accelerate the conversionof 3T3-L1 fibroblasts to adipocytes. J Lipid Res 43: 676-684.
56. Rubin BS, Murray MK, Damassa DA, King JC, Soto AM, 2001 Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ Health Perspect 109: 675-680.
57. Rubin BS, Soto AM 2009 Bisphenol A: Perinatal exposureand body weight. Mol Cell Endocrinol 304:55-62.
58. Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N, 2008 Bisphenol A at environmentallyrelevant doses inhibits adiponectin release fromhuman adipose tissue explants and adipocytes. EnvironHealth Perspect 116: 1642-1647
59. Nadal A, Alonso-Magdalena P, Ripoll C, Fuentes E, 2005 Disentangling the molecular mechanisms of action of endogenous and environmental estrogens. Pflugers Arch 44: 335-343.
60. Levin ER, 2005 Integration of the extranuclear andnuclear actions of estrogen. Mol Endocrinol 1: 1951-1959.
61. Nadal A, Ropero AB, Fuentes E, Soria B, 2001 The plasma membrane estrogen receptor: nuclear or unclear? Trends Pharmacol Sci 22: 597-599.
62. Valverde MA, Rojas P, Amigo J, et al, 1999 Acute activation of Maxi-Kchannels (hSlo) by estradiol bindingto the beta subunit. Science 285: 1929-1931.
63. Dunning BE, Foley JE, Ahrén B, et al, 2005 Alpha cellfunction in health and disease: influence of glucagonlikepeptide-1. Diabetologia 48: 1700-1713.
64. Quesada I, Tudurí E, Ripoll C, Nadal A, 2008 Physiologyof the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes. J Endocrino l199: 5-19.
65. Gopel SO, Kanno T, Barg S, Weng XG, Gromada J, Rorsman P, 2000 Regulation of glucagon release inmouse-cells by KATP channels and inactivation of TTX-sensitive Na+ channels. J Physiol 528: 509-520.
66. Rorsman P, Hellman B, 1988 Voltage-activated currentsin guinea pig pancreatic alpha 2 cells. Evidence forCa2+-dependent action potentials. J Gen Physiol 91:223-242.
67. Salehi A, Carlberg M, Henningson R, Lundquist I, 1996 Islet constitutive nitric oxide synthase: biochemicaldetermination and regulatory function. Am J Physio l270: C1634-1641.
68. Berts A, Ball A, Gylfe E, Hellman B, 1996 Suppression of Ca2+ oscillations in glucagon-producing alpha 2-cellsby insulin/glucose and amino acids. Biochim Biophys Acta 1310: 212-216.
69. Nadal A, Quesada I, Soria B, 1999 Homologous andheterologous asynchronicity between identified alpha-,beta- and delta-cells within intact islets of Langerhansin the mouse. J Physiol 517: (Pt 1) 85-93.
70. Gopel S, Zhang Q, Eliasson L, et al, 2004 Capacitancemeasurements of exocytosis in mouse pancreatic alpha-,beta- and delta-cells within intact islets of Langerhans. J Physiol 556: 711-726.
71. Gromada J, Ding WG, Barg S, Renström E, RorsmanP, 1997 Multisite regulation of insulin secretion bycAMP-increasing agonists: evidence that glucagonlikepeptide 1 and glucagon act via distinct receptors. Pflugers Arch 434: 515-524.
72. Opara EC, Atwater I, Go VL, 1988 Characterization andcontrol of pulsatile secretion of insulin and glucagon. Pancreas 3: 484-487.
73. Alonso-Magdalena P, Laribi O, Ropero AB, et al, 2005 Low doses of bisphenol A and diethylstilbestrol impairCa2+ signals in pancreatic alpha-cells through a nonclassicalmembrane estrogen receptor within intact islets ofLangerhans. Environ Health Perspect 113: 969-977.
74. Nadal A, Rovira JM, Laribi O, et al, 1998 Rapid insulino tropic effect of 17beta-estradiol via a plasmamembrane receptor. Faseb J 12: 1341-1348.
75. Nadal A, Ropero AB, Laribi O, Maillet M, Fuentes E, Soria B, 2000 Nongenomic actions of estrogens andxenoestrogens by binding at a plasma membrane receptorunrelated to estrogen receptor alpha and estrogen receptor beta. Proc Natl Acad Sci USA 97: 11603-11608.
76. Quesada I, Fuentes E, Viso-León MC, Soria B, Ripoll C, Nadal A, 2002 Low doses of the endocrine disruptorbisphenol-A and the native hormone 17beta-estradiolrapidly activate transcription factor CREB. Faseb J 16:1671-1673
77. Oetjen E, Diedrich T, Eggers A, Eckert B, Knepel W, 1994 Distinct properties of the cAMP-responsive element of the rat insulin I gene. J Biol Chem 269: 27036-27044.
78. Jhala US, Canettieri G, Screaton RA, et al, 2003 cAMPpromotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev 17: 1575-1580.
79. Adachi T, Yasuda K, Mori C, et al, 2005 Promotinginsulin secretion in pancreatic islets by means of bisphenol A and nonylphenol via intracellular estrogenreceptors. Food Chem Toxicol 43: 713-719.
80. Prentki M, Joly E, El-Assaad W, Roduit R, 2002 Malonyl-Co Asignaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes. Diabetes 51: Suppl 3: 405-413.
81. Lee DH, Lee IK, Porta M, Steffes M, Jacobs DR Jr, 2007 Relationship between serum concentrations of persistentorganic pollutants and the prevalence of metabolicsyndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey1999-2002. Diabetologia 50: 1841-1851.
82. Lee DH, Lim JS, Song K, Boo Y, Jacobs DR Jr, 2006 Graded associations of blood lead and urinary cadmiumconcentrations with oxidative-stress-related markersin the U.S. population: results from the third National Health and Nutrition Examination Survey. Environ Health Perspect 114: 350-354.
83. Lee DH, Steffes MW, Jacobs DR Jr, 2008 Can persistentorganic pollutants explain the association betweenserum gamma-glutamyl transferase and type 2 diabetes? Diabetologia 51: 402-407.
84. Lang IA, Galloway TS, Scarlett A, et al, 2008 Association of urinary bisphenol A concentration with medicaldisorders and laboratory abnormalities in adults. JAMA 300: 1303-1310.
85. vom Saal FS, Myers JP, 2008 Bisphenol A and risk of metabolic disorders. JAMA 300: 1353-1355.